Experience. Commitment. Results.
PB Bankshares Inc. (NASDAQ: PBBK) related to its sale to Norwood Financial Corp. Under the terms of the proposed transaction, PB Bankshares’ shareholders will have the option to elect to receive either 0.7850 shares of Norwood common stock or $19.75 in cash for each common share of PB Bankshares they own. The election is subject … Read more
WNS (Holdings) Limited (NYSE: WNS) related to its sale to Capgemini, S.E. for $76.50 per share in cash to WNS shareholders.
Olo Inc. (NYSE: OLO) related to its sale to Thoma Bravo for $10.25 per share in cash to Olo shareholders.
Aimei Health Technology Co., Ltd (NASDAQ: AFJKU) related to its merger with United Hydrogen Global, Inc., in which Aimei shareholders will be eligible for either (i) a redemption of their shares for $10.00; or (ii) becoming Class A shareholders in the combined company with minimal voting influence.
Launch One Acquisition Corp. (NASDAQ: LPAA) related to its merger with Minovia Therapeutics Ltd., in which Launch One shareholders will be eligible for a one-to-one exchange of shares in the new company, Mito US One Ltd.
Cartica Acquisition Corp. (OTCMKTS: CRTAF) related to its merger with Nidar Infrastructure Ltd., in which the pre-transaction equity value of Nidar implied by the proposed transaction’s terms is approximately $2.75 billion.
AlphaTime Acquisition Corp. (NASDAQ: ATMCR) related to its merger with HCYC Holding Co., in which AlphaTime shares will be cancelled in exchange for the right to receive a Class A share of HCYC Holding Company.
Gryphon Digital Mining, Inc. (NASDAQ: GRYP) related to its reverse merger with American Bitcoin Corp. Upon completion of this transaction American Bitcoin shareholders will own approximately 98% of Gryphon while existing Gryphon shareholders will retain only 2% of the post-closing ownership.
MRC Global Inc. (NYSE: MRC) related to its merger with DNOW, Inc. in which MRC shareholders will receive 0.9489 shares of DNOW common stock for each share of MRC common stock.
IGM Biosciences, Inc. (NASDAQ: IGMS) related to its merger to Concentra Biosciences, LLC for $1.247 in cash per share of IGM Biosciences common stock, plus one non-tradeable contingent value right, which represents the right to receive: (i) 100% of the closing net cash of IGM Biosciences in excess of $82.0 million; and (ii) 80% of any … Read more